🇺🇸 FDA
Patent

US 6692741

Treatment of acute lung injury and fibrosis with antagonists of &bgr;6-specific antibodies

expired A61KA61K38/39A61P

Quick answer

US patent 6692741 (Treatment of acute lung injury and fibrosis with antagonists of &bgr;6-specific antibodies) held by The Regents of the University of California expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/39, A61P, A61P1/16, A61P11/00